Intensity Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.79

-0.11 (-2.24%)

As of May 16, 2:26 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +672.4% upside

Low Target $31.85

Average Target $37.00

High Target $43.82

Current Price $4.79

Current
$4.79

Target
$37.00

$31.85 $37.00 avg $43.82

Scenario Analysis

Bear Case

$31.85

564.9%

Low target

Base Case

$37.00

+672.4%

Avg target

Bull Case

$43.82

+814.8%

High target

Risk/Reward

1.4x

Balanced

Price in Context

52-Week High

$43.50

-89.0% from high

52-Week Low

$4.63

+3.5% from low

Target vs 52W High

$37.00

-14.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%